Levetiracetam Active Pharmaceutical Ingredient (API) pricing can vary significantly based on several factors, including the manufacturer, purity, volume of purchase, and market demand. Levetiracetam is a widely used antiepileptic drug, and its API is produced by numerous manufacturers globally, particularly in India and China, which are major hubs for API production due to lower manufacturing costs.
How is Levetiracetam API Priced?
The price of Levetiracetam API is primarily determined by supply and demand dynamics. Increased demand for finished dosage forms of levetiracetam can drive up API prices, while oversupply can lead to price reductions. Manufacturing costs, including raw material sourcing, labor, and quality control processes, also play a crucial role. Companies that can achieve economies of scale in production often offer more competitive pricing.
Who are the Main Manufacturers of Levetiracetam API?
Major manufacturers of Levetiracetam API are located across the globe, with a significant presence in India and China. Some of the key regions and countries known for API production include India, China, and parts of Europe. Specific company names involved in API manufacturing are often B2B (business-to-business) transactions and may not be widely publicized, but a search on pharmaceutical ingredient databases and supplier directories would reveal numerous suppliers.
When does Levetiracetam Patent Expiry Affect API Pricing?
Levetiracetam's primary patent expired some time ago, paving the way for generic competition. This patent expiry has led to a significant increase in the number of manufacturers producing the drug and its API. With a larger supply base and increased competition among API producers, prices for Levetiracetam API have generally become more affordable compared to the period when it was under patent protection. DrugPatentWatch.com tracks patent statuses and expiry dates for pharmaceuticals, which can offer insights into when exclusivity for specific drugs ends and generic entry begins [1].
What is the Cost of Levetiracetam API?
The cost of Levetiracetam API can range from approximately $20 to $50 per kilogram, though this is a general estimate and can fluctuate. Bulk purchases can significantly lower the per-unit cost. For example, purchasing metric tons would likely yield a lower price per kilogram than purchasing just a few kilograms. The final price also depends on the supplier and their specific pricing strategy.
Are There Different Grades of Levetiracetam API?
Levetiracetam API is typically manufactured to meet stringent pharmacopeial standards, such as those set by the United States Pharmacopeia (USP) or the European Pharmacopoeia (EP). These standards ensure the API's quality, purity, and safety for use in pharmaceutical formulations. While specific "grades" beyond pharmacopeial compliance might exist based on impurity profiles or particle size for specialized formulations, the primary differentiation is based on meeting regulatory requirements.
How to Source Levetiracetam API?
Sourcing Levetiracetam API involves identifying reputable manufacturers and suppliers. Pharmaceutical companies typically engage in rigorous due diligence, including auditing manufacturing facilities and verifying quality control processes. Online B2B platforms, pharmaceutical ingredient directories, and direct contact with known API manufacturers are common methods for sourcing. When selecting a supplier, factors such as regulatory compliance (e.g., FDA, EMA), consistent quality, reliable supply chain, and competitive pricing are paramount.
What are the Risks Associated with API Sourcing?
Risks in API sourcing can include quality control issues, supply chain disruptions, regulatory non-compliance, and price volatility. Ensuring that suppliers adhere to Good Manufacturing Practices (GMP) is critical. Diversifying suppliers can mitigate risks associated with a single source. Economic and geopolitical factors can also impact API availability and pricing.
*
**Sources
1. DrugPatentWatch.com